Companies covered: Achieve Life Sciences (NASDAQ:ACHV), BioLineRx Ltd. (NASDAQ:BLRX), Biora Therapeutics Inc. (NASDAQ:BIOR), Bluejay Diagnostics Inc. (NASDAQ:BJDX), BriaCell Therapeutics Corp. (NASDAQ:BCTX), Pfizer, Inc. (NYSE:PFE), AbbVie Inc. (NYSE:ABBV), Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX), Tenax Therapeutics, Inc. (NASDAQ:TENX), United Therapeutics Corporation (NASDAQ:UTHR), Merck & Company, Inc. (NYSE:MRK), GlaxoSmithKline PLC (NYSE:GSK), Moderna (NASDAQ:MRNA), Johnson & Johnson (NYSE:JNJ), Kenvue Inc. (NYSE:KVUE), Omeros Corporation (NASDAQ:OMER), InflaRx NV (NASDAQ:IFRX), Agilon Health Inc. (NYSE:AGL), BioVie Inc. (NASDAQ:BIVI), Elutia Inc. (NASDAQ:ELUT), Inozyme Pharma Inc. (NASDAQ:INZY), PDS Biotechnology Corporation (NASDAQ:PDSB), SELLAS Life Sciences Group Inc. (NASDAQ:SLS), Theravance Biopharma, Inc. (NASDAQ:TBPH), Virpax Pharmaceuticals Inc. (NASDAQ:VRPX)
